New Access Capital

General Information
Company Name
New Access Capital
Founded Year
2003
Location (Offices)
Shanghai, China +1
Founders / Decision Makers
Number of Employees
14
Industries
Financial Services
Funding Stage
-
Social Media

New Access Capital - Company Profile

New Access Capital (NAC) is a venture capital firm based in Shanghai, China, founded in 2003 by Dr. Andrew Qian. NAC manages 7 RMB VC funds and focuses on investing in seed to late-stage technology companies across various industries including technology pertaining to IT (internet), ET (environment technology), FT (financial technology), BT (bio-tech), advanced manufacturing, AI, Blockchain, Cloud Computing, and Data.

Since its inception, NAC has seen success with nearly half of its portfolio companies achieving successful IPO/listing on major stock exchanges including NYSE, Nasdaq, Shanghai Stock Exchange, and National Equities Exchange Quotations. SSE STAR market. Operating from offices in Shanghai and Beijing, NAC continuously backs daring entrepreneurs in their journey to build a future through innovation and technology.

For more information, visit their website at http://www.newaccess.com.cn.

Funding Rounds & Investors of New Access Capital (0)

View All

There is no investment information

Latest News of New Access Capital

View All

No recent news or press coverage available for New Access Capital.

Similar Companies to New Access Capital

View All
CTS INTERNATIONAL LOGISTICS CORPORATION LIMITED--Shanghai China Head Office - Similar company to New Access Capital
CTS INTERNATIONAL LOGISTICS CORPORATION LIMITED--Shanghai China Head Office Global Logistics Solutions provider-since 1984 Subsidiaries in China:70+
Legend Capital君联资本 - Similar company to New Access Capital
Legend Capital君联资本 Established in 2001, Legend Capital is a leading Venture and Growth capital firm in China.
China Meheco Corporation - Similar company to New Access Capital
China Meheco Corporation Committed to advancing human health and pursuing excellence, striving to lead in the pharmaceutical industry.